放射性栓塞治疗市场规模、份额和成长分析：按设备、适应症、最终用户和地区划分－2026-2033年产业预测

2024年全球放射性栓塞治疗市场价值为13亿美元，预计将从2025年的14.4亿美元成长到2033年的31.7亿美元。预测期（2026-2033年）的复合年增长率预计为10.4%。

全球放射性栓塞治疗市场受到原发性和转移性肝癌发病率上升以及患者对标靶性、微创局部治疗日益增长的需求的显着影响。该市场涵盖各种设备，包括装置、微球、输送导管和治疗计划软体，这些设备能够将钇-90等放射性微球输送到肝肿瘤部位，与传统化疗相比，显着提高患者的生存率和生活品质。剂量测定、影像和导管设计方面的技术进步推动了临床应用的普及，而诊断影像技术的改进和个人化剂量测定则提高了治疗的精确度。有利的医保改革、强有力的临床证据以及亚太地区的市场扩张，都为该行业带来了积极影响。此外，放射性栓塞与免疫疗法的结合正在创造新的治疗机会，推动市场成长，并加剧供应商和製造商之间的竞争。

全球放射性栓塞治疗市场驱动因素

随着肝肿瘤发生率的不断上升，临床上对标靶局部治疗的需求日益增长，医疗机构正加速将放射乳化技术整合到治疗通讯协定中。由于难以手术治疗的肿瘤患者数量不断增加，人们越来越倾向于寻求在控制肿瘤的同时尽可能保留肝功能的替代疗法。这种转变促使治疗中心加强对必要设备的投入并加强人员训练。此外，转诊量的增加以及包括肿瘤内科医生和介入放射科医生在内的各专科医生之间合作的加强，凸显了放射乳化技术的治疗优势，并进一步推动了市场增长和服务的普及。

全球放射性栓塞治疗市场的限制因素

全球放射乳化治疗市场面临许多挑战，包括高昂的治疗费用和复杂的物流，这些都是阻碍其普及的主要障碍。这些因素对医疗机构和服务网络而言构成了巨大的进入门槛。对专用设备、耗材和设施维修的需求，以及对训练有素的多学科团队的依赖，往往使规模小规模的医疗中心难以提供放射乳化服务。此外，与排班、供应链管理以及肿瘤科、放射科和护理人员之间的协调相关的运营复杂性，也增加了行政负担，进一步阻碍了市场的快速扩张，并导致市场集中于大规模医疗机构。

放射乳剂治疗市场的全球趋势

全球放射乳化治疗市场正呈现出精准患者筛选的显着趋势，这极大地影响着治疗通讯协定并推动了市场需求。对患者细分的日益重视使临床医生能够进行多学科评估，并利用生物标记数据和先进的影像技术来识别最佳治疗候选者。这种个人化治疗方案不仅改善了临床疗效，也提升了治疗的价值认知，并有助于将其整合到复杂的诊疗路径中。此外，针对医疗专业人员的培训和决策支援工具的开发也推动了市场成长，增强了相关人员的信心，并强化了个人化癌症治疗框架内的转诊模式。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球放射性栓塞治疗市场规模：按设备类型和复合年增长率划分（2026-2033 年）

• 化疗栓塞装置
• 放射性珠子
• 配送系统

全球放射性栓塞治疗市场规模：依适应症及复合年增长率划分（2026-2033 年）

• 肝癌
• 结肠癌
• 其他肿瘤

全球放射性栓塞治疗市场规模：依最终用户和复合年增长率划分（2026-2033 年）

• 医院
• 专科诊所
• 其他的

全球放射性栓塞治疗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Boston Scientific Corporation
• CeloNova BioSciences
• Sensus Healthcare
• Merz Pharmaceuticals
• Biocompatibles
• Sirtex Medical Limited
• GRAIL, Inc.
• Terumo Corporation
• BTG International
• Medtronic
• ArcherDX
• Curium
• Nano-X Imaging
• Varian Medical Systems
• Elekta
• Innova Medical
• Epigenetics
• AtriCure
• GE Healthcare
• Siemens Healthineers

结论与建议

Global Radioembolization Therapy Market size was valued at USD 1.3 Billion in 2024 and is poised to grow from USD 1.44 Billion in 2025 to USD 3.17 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026-2033).

The global radioembolization therapy market is significantly influenced by the rising prevalence of primary and metastatic liver cancers, alongside the growing preference for targeted, minimally invasive locoregional treatments. Comprising devices, microspheres, delivery catheters, and planning software, this market facilitates the administration of radioactive microspheres like yttrium-90 to hepatic tumors, offering notable survival and quality-of-life advantages over traditional chemotherapy. Technological advancements in dosimetry, imaging, and catheter design have fostered greater clinical adoption, while improved diagnostic imaging and personalized dosimetry enhance treatment precision. The sector benefits from favorable reimbursement reforms, strong clinical evidence, and market expansion into Asia Pacific. Additionally, combining radioembolization with immunotherapies generates new treatment opportunities, increasing market growth and competitiveness among providers and manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radioembolization Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radioembolization Therapy Market Segments Analysis

Global radioembolization therapy market is segmented by device type, indication, end user and region. Based on device type, the market is segmented into Chemoembolization Devices, Radioactive Beads and Delivery Systems. Based on indication, the market is segmented into Liver Cancer, Colorectal Cancer and Other Tumors. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Radioembolization Therapy Market

The growing incidence of liver tumors is driving a heightened clinical demand for targeted locoregional therapies, prompting healthcare providers to incorporate radioembolization into their treatment protocols. With an increasing number of patients presenting with tumors that are not viable for surgical intervention, there is a significant shift towards exploring alternative therapies that prioritize tumor management while maintaining liver functionality. This shift encourages treatment centers to invest in necessary equipment and staff training. Additionally, the trend of increased referrals and collaborative efforts among specialists, including oncologists and interventional radiologists, underscores the therapeutic advantages of radioembolization, further propelling market growth and service availability.

Restraints in the Global Radioembolization Therapy Market

The Global Radioembolization Therapy market faces significant challenges due to high procedural costs and intricate logistics, which act as major barriers to widespread adoption. These factors impose considerable entry hurdles for healthcare providers and service networks. The substantial capital investment required for specialized equipment, consumables, and facility modifications, coupled with the necessity for well-trained multidisciplinary teams, often discourages smaller medical centers from offering radioembolization services. Additionally, the operational complexities related to scheduling, supply chain management, and coordinating efforts among oncology, radiology, and nursing staff increase administrative workload, further hindering rapid expansion and leading to market concentration in larger institutions.

Market Trends of the Global Radioembolization Therapy Market

The Global Radioembolization Therapy market is witnessing a notable trend towards precision patient selection, which is significantly influencing treatment protocols and driving demand. Increased focus on refined patient stratification enables clinicians to engage in multidisciplinary evaluations and leverage advanced imaging techniques alongside biomarker data to identify optimal candidates for therapy. This tailored approach not only enhances clinical outcomes but also boosts the perceived value of treatment, facilitating its integration into complex care pathways. Furthermore, the market growth is underpinned by the development of provider training and decision support tools, fostering confidence among stakeholders and enhancing referral patterns within personalized oncology frameworks.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Radioembolization Therapy Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Chemoembolization Devices
• Radioactive Beads
• Delivery Systems

Global Radioembolization Therapy Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Liver Cancer
• Colorectal Cancer
• Other Tumors

Global Radioembolization Therapy Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Radioembolization Therapy Market Size & CAGR (2026-2033)

• North America (Device Type, Indication, End User)
  • US
  • Canada
• Europe (Device Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Indication, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeloNova BioSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensus Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocompatibles
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GRAIL, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTG International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArcherDX
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curium
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano-X Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innova Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epigenetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations